# Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

> **NCT01810315** · PHASE1 · COMPLETED · sponsor: **CONRAD** · enrollment: 40 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** TFV 1% gel
- **DRUG:** Estradiol vaginal cream

## Key facts

- **NCT ID:** NCT01810315
- **Lead sponsor:** CONRAD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01810315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01810315, "Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01810315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*